Kiromic BioPharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 02/14/2023 | 549,944 | $99,375 | 100.00% | 3.37% |
| ZEKE CAPITAL ADVISORS, LLC | 02/14/2023 | 107,000 | $19,335 | 0.00% | 0.66% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2023 | 40,962 | $7,000 | 0.00% | 0.25% |
| UBS GROUP AG | 02/08/2023 | 38,757 | $6,976 | 109.38% | 0.24% |
| VIRTU FINANCIAL LLC | 02/15/2023 | 31,810 | $6,000 | 100.00% | 0.19% |
| STATE STREET CORP | 05/15/2023 | 16,976 | $3,056 | 0.00% | 0.10% |
| CITADEL ADVISORS LLC | 02/14/2023 | 12,100 | $2,178 | 100.00% | 0.07% |
| WEALTHTRUST AXIOM LLC | 01/31/2023 | 10,000 | $1,807 | 0.00% | 0.06% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/10/2023 | 4,675 | $1,000 | -4.08% | 0.03% |
| PNC FINANCIAL SERVICES GROUP, INC. | 02/10/2023 | 4,000 | $724 | 0.00% | 0.02% |
| MORGAN STANLEY | 02/14/2023 | 1,206 | $218 | 100.00% | 0.01% |
| GROUP ONE TRADING, L.P. | 02/09/2023 | 192 | $35 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2023 | 77 | $14 | 100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 01/30/2023 | 0 | $0 | 0.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 02/02/2023 | 0 | $0 | -100.00% | 0.00% |
| CETERA ADVISOR NETWORKS LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| REDMOND ASSET MANAGEMENT, LLC | 02/06/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kiromic BioPharma, Inc. institutional Ownership - FAQ's
During the previous two years, 1 institutional investors and hedge funds held shares of Kiromic BioPharma, Inc.. The most heavily invested institutionals were:
ZEKE CAPITAL ADVISORS, LLC: 107,000
4.93% of Kiromic BioPharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 107,000 shares in the last 24 months. This purchase volume represents approximately $99,510 in transactions.